Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)

China flag China · Delayed Price · Currency is CNY
14.09
-0.17 (-1.19%)
At close: Mar 11, 2026
12.81%
Market Cap 5.88B
Revenue (ttm) 786.51M
Net Income (ttm) 74.61M
Shares Out 417.60M
EPS (ttm) 0.18
PE Ratio 78.89
Forward PE n/a
Dividend 0.10 (0.70%)
Ex-Dividend Date n/a
Volume 1,493,400
Average Volume 2,326,672
Open 14.26
Previous Close 14.26
Day's Range 14.05 - 14.26
52-Week Range 11.42 - 22.69
Beta -0.16
RSI 39.05
Earnings Date Apr 24, 2026

About SHE:002907

Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, soft capsules, powder injections, freeze-dried powders, injections, chemical raw materials, and small volume injections. It provides its products for the treatment of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. Chongqing Pharscin Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Chongqing, China. [Read more]

Sector Healthcare
Founded 1996
Employees 1,384
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002907
Full Company Profile

Financial Performance

In 2024, SHE:002907's revenue was 774.82 million, an increase of 12.04% compared to the previous year's 691.54 million. Earnings were 76.73 million, an increase of 134.66%.

Financial Statements

News

There is no news available yet.